feed,title,long_url,short_url
Investing,Replimune stock soars after FDA accepts BLA resubmission for melanoma drug,https://www.investing.com/news/stock-market-news/replimune-stock-soars-after-fda-accepts-bla-resubmission-for-melanoma-drug-93CH-4296765,
